Aethlon Medical Company Insiders
AEMD Stock | USD 0.58 0.15 34.88% |
Aethlon Medical employs about 14 people. The company is managed by 7 executives with a total tenure of roughly 9 years, averaging almost 1.0 years of service per executive, having 2.0 employees per reported executive. Evaluation of Aethlon Medical's management performance can provide insight into the firm performance.
Aethlon |
Aethlon Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.5046) % which means that it has lost $0.5046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0538) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical's management efficiency ratios could be used to measure how well Aethlon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of December 21, 2024, Return On Tangible Assets is expected to decline to -1.55. The current year's Return On Capital Employed is expected to grow to -1.87. At present, Aethlon Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 418.6 K, whereas Intangible Assets are forecasted to decline to 1,045.Aethlon Medical Workforce Comparison
Aethlon Medical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,180. Aethlon Medical claims roughly 14.0 in number of employees contributing just under 2% to equities under Health Care industry.
Aethlon Medical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aethlon Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aethlon Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Aethlon Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cipriani Guy F. over three weeks ago Acquisition by Cipriani Guy F. of 120883 shares of Aethlon Medical at 2.52 subject to Rule 16b-3 | ||
Cipriani Guy F. over two months ago Acquisition by Cipriani Guy F. of 100200 shares of Aethlon Medical at 1.41 subject to Rule 16b-3 | ||
Shah Chetan over two months ago Disposition of 3289 shares by Shah Chetan of Aethlon Medical at 0.466 subject to Rule 16b-3 | ||
Rossetti Angela over two months ago Acquisition by Rossetti Angela of 51370 shares of Aethlon Medical subject to Rule 16b-3 | ||
Gikakis Nicolas over six months ago Acquisition by Gikakis Nicolas of 32894 shares of Aethlon Medical at 1.52 subject to Rule 16b-3 | ||
Guy Cipriani over six months ago Acquisition by Guy Cipriani of 120883 shares of Aethlon Medical at 2.52 subject to Rule 16b-3 | ||
Edward Broenniman over six months ago Acquisition by Edward Broenniman of 34247 shares of Aethlon Medical subject to Rule 16b-3 | ||
Rossetti Angela over six months ago Insider Trading |
Aethlon Medical Notable Stakeholders
An Aethlon Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aethlon Medical often face trade-offs trying to please all of them. Aethlon Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aethlon Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
James MBA | CFO, CEO | Profile | |
Richard Tullis | Chief Science Officer and VP | Profile | |
MBA BS | Chief Officer | Profile | |
MD Fisher | Director CEO | Profile | |
Steven MD | Chief Officer | Profile | |
Lee Arnold | Chief Officer | Profile | |
Sunil Sawhney | Head Studies | Profile |
About Aethlon Medical Management Performance
The success or failure of an entity such as Aethlon Medical often depends on how effective the management is. Aethlon Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aethlon management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aethlon management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.48) | (1.55) | |
Return On Capital Employed | (1.97) | (1.87) | |
Return On Assets | (1.48) | (1.55) | |
Return On Equity | (2.12) | (2.01) |
Please note, the presentation of Aethlon Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aethlon Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aethlon Medical's management manipulating its earnings.
Aethlon Medical Workforce Analysis
Traditionally, organizations such as Aethlon Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aethlon Medical within its industry.Aethlon Medical Manpower Efficiency
Return on Aethlon Medical Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 872K | |
Net Loss Per Executive | 1.7M | |
Working Capital Per Employee | 314K | |
Working Capital Per Executive | 628K |
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |